According to the report, the respiratory panel testing market in EMEA was valued over US$ 1.6 Bn in 2020 and is projected to expand at a CAGR of 5.1% from 2021 to 2031.
Albany NY, United States: Europe and Middle East & Africa Respiratory Panel Testing Market: Introduction
According to the report, the respiratory panel testing market in EMEA was valued over US$ 1.6 Bn in 2020 and is projected to expand at a CAGR of 5.1% from 2021 to 2031. Respiratory panel testing is a diagnostic panel used for the detection of virus, bacteria, fungi, parasites, and other pathogens. Pathogens cause various respiratory diseases, which are life threatening. This increases the need of accurate identification of the pathogens. Respiratory tract infections are the most common diseases spreading across regions. Most respiratory panels available in the market offer high performance and have clinical significance in rapid pathogen detection.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=84240
Key Strategies by Leading Players to Boost Europe and Middle East & Africa Respiratory Panel Testing Market
In September 2021, Roche signed a definitive share purchase agreement with TIB Molbiol Group to expand PCR-test portfolio against infectious diseases. The acquisition will enhance Roche’s portfolio of molecular diagnostic solutions with a wide range of assays for infectious diseases, such as the identification of SARS-CoV-2 variants.
In June 2021, bioMerieux SA launched EPISEQ SARS-COV-2, a genomic software solution to support microbiology labs in identification and reporting from raw sequencing data related to SARS-CoV-2 variants.
In June 2020, DiaSorin Molecular received CE mark for its Simplexa Flu A/B & RSV Direct Gen II assay for influenza and respiratory syncytial virus (RSV). In April 2021, altona Diagnostics GmbH launched the AltoStar HIV RT-PCR Kit 1.5, an in vitro diagnostic test, based on real-time RT-PCR technology, for the detection and quantification of human immunodeficiency virus type 1 (HIV-1) specific RNA (groups M, N and O) in human EDTA plasma.
In May 2021, CerTest Biotec S.L. entered into partnership with BD to detect COVID-19 in saliva. Under the terms of the partnership, VIASURE SARS-CoV-2 (N1+N2) Real Time PCR Detection Kit, which is used in the BD MAX Molecular Diagnostic System, will be sold through BD’s distribution network.
Request for Analysis of COVID-19 Impact on Respiratory Panel Testing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=84240
Viruses Segment to Lead Europe and Middle East & Africa Respiratory Panel Testing Market
In terms of specimen type, the respiratory panel testing market in EMEA has been bifurcated into viruses and bacteria. The viruses segment held major market share in 2020, owing to the availability of the respiratory panel testing for diverse range of viruses. Onset of coronavirus infections across Europe and Middle East & Africa is anticipated to increase diagnosis testing. Surge in incidence of viral infections across the regions is expected to boost the growth of the segment in the next few years.
According to WHO, countries with the highest death toll due to coronavirus are Russia, the U.K., Italy, and France, each having reported over 100,000 deaths in 2020. These statistics are likely to boost panel testing for respiratory diseases across the region.
Syndromic Full Multiplex Panel Segment to Dominate Europe and Middle East & Africa Respiratory Panel Testing Market
Based on panel type, the respiratory panel testing market in EMEA has been classified into syndromic full multiplex panel and low plex panel. The syndromic full multiplex panel segment accounted for major market share in 2020, owing to its preference over low plex panel. Syndromic full multiplex panel uses one test to target multiple pathogens for faster detection. This panel has enabled laboratories to rapidly identify virus, bacteria, parasites, fungi, and other organism at higher specificity and sensitivity.
Hospitals to be Key End-user
In terms of end-user, the respiratory panel testing market in EMEA has been divided into hospital point-of-care testing, ref laboratories, hospitals, and others. Hospitals complement and amplify the effectiveness of many other parts of the health system, providing continuous availability of services for acute and complex conditions. These concentrate scarce resources within well-planned referral networks to respond efficiently to population health needs. Increase in admission of patients suffering from respiratory diseases is likely to drive the segment during the forecast period.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=84240
Europe to Lead Europe and Middle East & Africa Respiratory Panel Testing Market
Europe dominated the respiratory panel testing market in EMEA in 2020, accounting for prominent share. Growing outbreak of coronavirus disease and other infectious diseases, well-established health care system, advanced health care facilities, growing molecular diagnostics market, and presence of key players offering respiratory panel tests are anticipated to boost the growth of the market in the region during the forecast period.
Germany is expected to be an attractive market from 2021 to 2031. The country is likely to account for significant share of the market in Europe during the forecast period. This is attributed to increase in cases of infections, rise in admission of patients in hospitals, surge in number of laboratories, and technological advancements leading to the availability of diagnostic kits for respiratory disease testing.
Buy now Respiratory Panel Testing Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=84240<ype=S
Competition Landscape
The respiratory panel testing market in EMEA is fragmented due to presence of large number of leading players. Key players operating in the market include F. Hoffmann-La Roche Ltd., bioMerieux SA, Medline Industries, Inc., Becton, Dickinson & Company, altona Diagnostics GmbH, CerTest Biotec S.L., Anatolia Geneworks, Seegene, Inc., DiaSorin S.p.A. (Luminex), QIAGEN, and Biocartis.
More Trending Reports by Transparency Market Research:
Home Diagnostics Market The healthcare industry is constantly seeking to address patients’ unmet well-being needs for a variety of acute and chronic diseases. Concurrently, governments are attempting to keep healthcare spending sustainable, while granting equal access to high-quality care. With the rising prevalence of several diseases, the home diagnostics market is trending for its convenience for the patient as well as hospital facilities.
Cell & Tissue Preservation Market The reopening of fertility care services in the midst of the COVID-19 pandemic lead to numerous concerns that need immediate addressing. Companies in the cell & tissue preservation market are gaining awareness about these concerns to prevent the risk of cross-contamination and transmission at the fertility centers. Due to the novelty of the disease, there is a need for more information confirming an association of coronavirus with reproductive tissues, embryos, and gametes.
Generic Injectables Market Manufacturers in the generic injectables market are becoming future-ready by maintaining adequate supply chains to prevent vulnerabilities caused by potential COVID-19-like situations. Drug firms including Zydus Cadila are observed to significantly reduce the price of its generic version of Remdesivir namely Remdac. Companies are taking the advantage of government programs and financial schemes offered by the BFSI sector to streamline their business activities as per the volatile market sentiments.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/